Amilco

Amilco is a biotechnology company focused on the development of therapeutic solutions for protein misfolding diseases, with a primary emphasis on amyloidosis and neurodegenerative conditions like Alzheimer's disease. The company leverages its expertise in amyloid biology to identify and advance small molecule candidates designed to inhibit the formation or promote the clearance of toxic protein aggregates. Amilco's research and development efforts are centered on addressing high unmet medical needs in the field of proteinopathy through targeted molecular interventions. The company maintains a pipeline of programs at various stages of clinical and preclinical development, aiming to provide disease-modifying treatments for patients suffering from systemic and localized amyloid-related disorders.